91´óÉñ

Study Location | Status</h2>\r\n<p>91´óÉñ Children’s Health, Pensacola | <b>Enrolling&nbsp;&nbsp;</b><br>\r\n&nbsp;</p>\r\n<h2>Participant&nbsp;Eligibility</h2>\r\n<p>Clinical trials have inclusion and exclusion requirements that determine eligibility. Key requirements are listed below. Please note there may be additional qualifications.</p>\r\n<p><b>At the time of consent, participants must be:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b></b></p>\r\n<ul>\r\n<li>Ages 2 to 14 years old (female).</li>\r\n<li>Ages 2 to 16 years old (male).</li>\r\n</ul>\r\n<h2><br>\r\nAbout the Study</h2>\r\n<p><b>Formal Study Name:&nbsp;</b>A Multicenter, Observational Study to Characterize Growth in Children with Idiopathic Short Stature</p>\r\n<p><b>Study Type: </b>Observational&nbsp;(researchers observe and record without intervening)</p>\r\n<p><b>Study ID:&nbsp;</b>2231160</p>\r\n<p><b>Sponsor/Coordinating Site:&nbsp;</b>&nbsp;BioMarin Pharmaceutical</p>\r\n<p><b>Start Date:&nbsp;</b>August 2024</p>\r\n<p><b>Completion Date (estimated):&nbsp;</b>December 2040</p>\r\n<p><b>Enrolling Healthy Volunteers?&nbsp;</b>No<br>\r\n&nbsp;</p>\r\n<h2>What’s Involved</h2>\r\n<p>During this study, your child may have up to&nbsp;38 visits. Some of the tests and procedures are similar to what happens during regular care, like&nbsp;vital signs, height and weight checks, and physical exams. Others are specific to the study, such as&nbsp;questionnaires about your child’s quality of life.</p>\r\n<p>Other requirements include:</p>\r\n<ul>\r\n<li><b>Blood samples</b>&nbsp;will be collected&nbsp;twice: Once during the screening visit and again on Day 1. The total amount of blood taken during the study is&nbsp;about 10 mL&nbsp;(roughly two teaspoons).</li>\r\n<li><b>Height and weight</b>&nbsp;will be measured at&nbsp;every study visit.</li>\r\n</ul>\r\n"}} id=text-1a4b9d24f9 class=cmp-text>

Study Location | Status

91´óÉñ Children’s Health, Pensacola | EnrollingÌýÌý
Ìý

ParticipantÌýEligibility

Clinical trials have inclusion and exclusion requirements that determine eligibility. Key requirements are listed below. Please note there may be additional qualifications.

At the time of consent, participants must be:ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

• Ages 2 to 14 years old (female).
• Ages 2 to 16 years old (male).

About the Study

Formal Study Name:ÌýA Multicenter, Observational Study to Characterize Growth in Children with Idiopathic Short Stature

Study Type: ObservationalÌý(researchers observe and record without intervening)

Study ID:Ìý2231160

Sponsor/Coordinating Site:ÌýÌýBioMarin Pharmaceutical

Start Date:ÌýAugust 2024

Completion Date (estimated):ÌýDecember 2040

Enrolling Healthy Volunteers?ÌýNo
Ìý

What’s Involved

During this study, your child may have up toÌý38 visits. Some of the tests and procedures are similar to what happens during regular care, likeÌývital signs, height and weight checks, and physical exams. Others are specific to the study, such asÌýquestionnaires about your child’s quality of life.

Other requirements include:

• Blood samplesÌýwill be collectedÌýtwice: Once during the screening visit and again on Day 1. The total amount of blood taken during the study isÌýabout 10 mLÌý(roughly two teaspoons).
• Height and weightÌýwill be measured atÌýevery study visit.